Citation Impact
Citing Papers
Development of an mRNA-lipid nanoparticle vaccine against Lyme disease
2023 StandoutNobel
More insight into the fate of biomedical meeting abstracts: a systematic review
2003
Publication bias in gastroenterological research – a retrospective cohort study based on abstracts submitted to a scientific meeting
2002
The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis
2009 Standout
¿Cuántos alcanzan la meta? Destino de los resúmenes presentados en el XXIV Congreso de la Asociación Española para el Estudio del Hígado y su evolución en el tiempo
2007
Publication rate of abstracts from the annual ASTRO meeting: Comparison with other organizations
2005
Management of adverse events associated with idelalisib treatment: expert panel opinion
2015
Presentation and subsequent publication rates of phase I oncology clinical trials
2005
Publication Rates of Abstracts Presented at Annual Musculoskeletal Tumor Society Meetings
2003
A modified test for small‐study effects in meta‐analyses of controlled trials with binary endpoints
2005 Standout
Characterization of T-cell repertoire in hairy cell leukemia patients before and after recombinant immunotoxin BL22 therapy
2005
Comparison of Two Methods to Detect Publication Bias in Meta-analysis
2006 Standout
The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials
2001 Standout
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
2009 Standout
Publication rates of abstracts presented at annual scientific meetings: How does the Royal Australian and New Zealand College of Radiologists compare?
2004
Post-treatment Lyme Disease as a Model for Persistent Symptoms in Lyme Disease
2020
Abstract to publication ratio for papers presented at scientific meetings: How does emergency medicine compare?
2001
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
2015 Standout
PUBLICATION BIAS IN PAPERS PRESENTED TO THE AUSTRALIAN ORTHOPAEDIC ASSOCIATION ANNUAL SCIENTIFIC MEETING
2006
Publication Bias in Orthopaedic Research: An Analysis of Scientific Factors Associated with Publication in The Journal of Bone and Joint Surgery (American Volume)
2008
Fate of abstracts published in the proceedings of the first annual Perinatal Society of Australia and New Zealand Congress in 1997
2002
Presentation in relation to publication of results from clinical trials
2006
Fludarabine, cyclophosphamide and mitoxantrone in the treatment of resistant or relapsed chronic lymphocytic leukaemia
2002
Why Does Social Exclusion Hurt? The Relationship Between Social and Physical Pain.
2005 Standout
Publication Bias in Abstracts Presented to the Annual Meeting of the American Academy of Orthopaedic Surgeons
2007
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
2013 Standout
Subsequent publication of abstracts presented at the International Association of Paediatric Dentistry meetings
2008
Publication Rates of Scientific Presentations at the American Association of Hip and Knee Surgeons Annual Meetings From 1996 to 2001
2006
The International Society for the Study of the Lumbar Spine
2006
Preliminary Reports and the Rates of Publication of Follow-up Reports in Peer-reviewed, Indexed Journals
2001
Do Pressures to Publish Increase Scientists' Bias? An Empirical Support from US States Data
2010 Standout
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
2011 Standout
Subsequent Publication of Orally Presented Original Studies within 5 Years after 1995 RSNA Scientific Assembly
2004
Measuring inconsistency in meta-analyses
2003 Standout
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials
2011 Standout
Towards evidence based radiation oncology: improving the design, analysis, and reporting of clinical outcome studies in radiotherapy
1998
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Publication pattern of papers presented at the American Society for Surgery of the Hand Annual Meeting
1996
Assessment of abstracts submitted to the annual scientific meeting of the Royal Australian and New Zealand College of Radiologists
2006
Follicular lymphoma international prognostic index
2006
Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia
2010 Standout
Funnel plots for detecting bias in meta-analysis
2001 Standout
Scientific papers presented at the 2000–2001 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) meetings: publication rates during the period 2000–2004
2006
Peer‐reviewed publication following presentation at a regional surgical meeting
1999
Due to low infection rates no routine anti‐infective prophylaxis is required in younger patients with chronic lymphocytic leukaemia during fludarabine‐based first line therapy
2006
Metabolic Syndrome and Risk of Incident Cardiovascular Events and Death
2007 Standout
Factors associated with acceptance and full publication of GI endoscopic research originally published in abstract form
2001
The Long-Term Health Consequences of Child Physical Abuse, Emotional Abuse, and Neglect: A Systematic Review and Meta-Analysis
2012 Standout
Factors Associated with Publication Following Presentation at a Transplantation Meeting
2006
Paul Ehrlich's magic bullet concept: 100 years of progress
2008 Standout
Publication Rates Following Pancreas Meetings
2001
The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed
2005 Standout
Fate of abstracts from the Paris 1995 European Society of Anaesthesiologists meeting
2002
The PI3K Pathway in Human Disease
2017 Standout
Publication Bias in Editorial Decision Making
2002
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Serum Inflammatory Mediators as Markers of Human Lyme Disease Activity
2014
Lyme borreliosis
2011 Standout
Publication rates of scientific papers presented at the Otorhinolarygological Research Society meetings
2001
Factors Associated With Failure to Publish Large Randomized Trials Presented at an Oncology Meeting
2003
Unpublished Research From a Medical Specialty Meeting
1998
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
Paraneoplastic syndromes of the CNS
2008
Positive-Outcome Bias and Other Limitations in the Outcome of Research Abstracts Submitted to a Scientific Meeting
1998
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression
2015 Standout
Industry sponsorship and research outcome
2012 Standout
Determinants of abstract acceptance for the Digestive Diseases Week – a cross sectional study
2001
Publication Patterns of Papers Presented at the Annual Meeting of The American Academy of Orthopaedic Surgeons*
1997
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
2003 Standout
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
Prevalence of Depression, Depressive Symptoms, and Suicidal Ideation Among Medical Students
2016 Standout
Pentostatin, Cyclophosphamide, and Rituximab Is an Active, Well-Tolerated Regimen for Patients With Previously Treated Chronic Lymphocytic Leukemia
2006
Factors Influencing the Publication of Randomized Controlled Trials in Child Health Research
2004
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
Publication of Abstracts Submitted to the Annual Meeting of the Pediatric Orthopaedic Society of North America
2000
Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia
2005
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials
2001 Standout
Full publication of results initially presented in abstracts
2007 Standout
Factors that limit the quality, number and progress of randomised controlled trials.
1999
Consistency of Phase III Clinical Trial Abstracts Presented at an Annual Meeting of the American Society of Clinical Oncology Compared With Their Subsequent Full-Text Publications
2008
Factors Influencing the Effectiveness of Relationship Marketing: A Meta-Analysis
2006 Standout
Scientific meeting abstracts: significance, access, and trends.
1998
Do peer-reviewed journal papers result from meeting abstracts of the Biennial Conference on the Biology of Marine Mammals?
1999
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
2014 Standout
Publication and related biases.
2000
Fate of abstracts from the Paris 1995 European Society of Anaesthesiologists meeting
2002
The fate of neuroradiologic abstracts presented at national meetings in 1993: rate of subsequent publication in peer-reviewed, indexed journals.
1999
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Measurement of Organ-Specific and Acute-Phase Blood Protein Levels in Early Lyme Disease
2019 StandoutNobel
Publication rates of scientific presentations in Turkish national radiology congresses.
2005
Publication Outcome for Research Presented at the Vascular Society of Great Britain and Ireland Annual Meetings
2007
World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997
1999 Standout
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
Conducting Meta-Analyses inRwith themetaforPackage
2010 Standout
Publication bias in clinical trials due to statistical significance or direction of trial results
2009 Standout
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
2010 Standout
Industry sponsorship and research outcome
2017 Standout
Quantifying Publication Bias in Meta-Analysis
2017 Standout
DSM-IV Pain Disorder: a case against the diagnosis
2000
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Works of Candis Morrison being referenced
Diagnostic challenges of early Lyme disease: Lessons from a community case series
2009
ANNA-2: An Antibody Associated with Paraneoplastic Opsoclonus in a Patient with Large-Cell Carcinoma of the Lung with Neuroendocrine Features—Correlation of Clinical Improvement with Tumor Response
2004
Overlooked Physical Diagnoses in Chronic Pain Patients Involved in Litigation, Part 2
1996
The fate of abstracts submitted to a cancer meeting: Factors which influence presentation and subsequent publication
1992
Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignancies
2000
Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignancies
2000